News

­

Gamida Cell $40MM Financing to support its Phase 3 Trial

Israel Biotech Fund participated in Gamida Cell’s $40MM financing round which shall support the ongoing Phase 3 trial of the its FDA Breakthrough Designated clinical-stage product, NiCord, to facilitate bone marrow transplantation. […]

By |June 19th, 2017|Categories: Uncategorized|Comments Off on Gamida Cell $40MM Financing to support its Phase 3 Trial

Israel Biotech Fund Co-Founder and General Partner Recognized for Contribution to Liquid Biopsy Innovation

Israel Biotech Fund is proud to announce that its Co-Founder and General Partner...

By |April 3rd, 2017|Categories: Uncategorized|Comments Off on Israel Biotech Fund Co-Founder and General Partner Recognized for Contribution to Liquid Biopsy Innovation

Israel Biotech Fund invests in Pharma Two B

A $30MM funding round in Pharma Two B was led by Israel Biotech Fund, which  syndicated the investment with leading US and Israeli investors. Read the full Article

By |February 27th, 2017|Categories: Uncategorized|Comments Off on Israel Biotech Fund invests in Pharma Two B

Israel Biotech Fund begins investing

Israel Biotech Fund, founded to make investments in the Israeli biotech industry, today selected cancer drug developer Vidac for its first investment.
Read the full Article

By |July 3rd, 2016|Categories: Biotechnology|Comments Off on Israel Biotech Fund begins investing

Biogen invests in a newly formed Israeli fund

Biogen invests in a newly formed fund dedicated to investment in Israeli and Israeli related biotech companies.
Read the full Article

By |November 19th, 2015|Categories: Biotechnology, Fund Raising|Comments Off on Biogen invests in a newly formed Israeli fund